Elisabeth Sandoval

Insider Reports History

Location
C/O Kythera Biopharmaceuticals, Inc., 30930 Russell Ranch Road, 3 Rd Floor, Westlake Village, CA
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Elisabeth Little
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elisabeth Sandoval:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PROCEPT BioRobotics Corp Director Common Stock 12.6K $667K $53.11 Jun 10, 2025 Direct
PROCEPT BioRobotics Corp Director Stock Option (Right to Buy) 2.77K $11.5K $4.56 Jun 10, 2025 Direct
VYNE Therapeutics Inc. Director Stock Option (right to buy) 20K Dec 12, 2024 Direct
Intersect ENT, Inc. Director Stock Options (Right to buy) 0 $28.25 May 13, 2022 Direct
Satsuma Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 Jun 8, 2023 Direct

Insider Reports Filed by Elisabeth Sandoval

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRCT PROCEPT BioRobotics Corp Jun 10, 2025 2 $0 4 Jun 12, 2025 Director
VYNE VYNE Therapeutics Inc. Dec 12, 2024 1 $0 4 Dec 13, 2024 Director
PRCT PROCEPT BioRobotics Corp Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
VYNE VYNE Therapeutics Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
VYNE VYNE Therapeutics Inc. Dec 13, 2023 1 $0 4 Dec 15, 2023 Director
PRCT PROCEPT BioRobotics Corp Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 8, 2023 4 $0 4 Jun 8, 2023 Director
VYNE VYNE Therapeutics Inc. Aug 10, 2022 1 $0 4 Aug 12, 2022 Director
PRCT PROCEPT BioRobotics Corp Jun 7, 2022 2 $75K 4 Jun 9, 2022 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director
XENT Intersect ENT, Inc. May 13, 2022 1 -$449K 4 May 16, 2022 Director
PRCT PROCEPT BioRobotics Corp Oct 21, 2021 1 $200K 4 Oct 25, 2021 Director
VYNE VYNE Therapeutics Inc. Jul 19, 2021 1 $0 4 Jul 20, 2021 Director